Published in J Chromatogr on September 26, 1973
Direct measurement of propranolol bioavailability during accumulation to steady-state. Br J Clin Pharmacol (1978) 1.60
Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs. Br J Clin Pharmacol (1980) 0.90
A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects. Br J Clin Pharmacol (1985) 0.87
Flurbiprofen interaction with single doses of atenolol and propranolol. Br J Clin Pharmacol (1984) 0.82
Diazepam/beta-adrenoceptor antagonist interactions. Br J Clin Pharmacol (1984) 0.82
Plasma concentrations and cardiotoxic effects of desipramine and protriptyline in the rat. Br J Pharmacol (1977) 0.80
Proceedings of the British Pharmacological Society 8th-10th September, 1982. Abstracts. Br J Pharmacol (1982) 0.75
Improved fluorimetric assay of plasma propranolol. Br J Clin Pharmacol (1976) 0.75
Development and Validation of a HPTLC Method for Simultaneous Quantitation of Flunarizine Dihydrochloride and Propranolol Hydrochloride in Capsule Dosage Form. Indian J Pharm Sci (2013) 0.75
Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin Pharmacol Ther (1973) 2.14
Rapid identification of Vibrio vulnificus on nonselective media with an alkaline phosphatase-labeled oligonucleotide probe. Appl Environ Microbiol (1993) 1.94
Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation (1975) 1.92
The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? Circ Res (1999) 1.79
Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine. Circulation (1972) 1.73
Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig. Circ Res (1965) 1.63
Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation (1991) 1.58
N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia (1975) 1.54
Delayed absorption of phenylbutazone caused by desmethylimipramine in humans. Eur J Pharmacol (1970) 1.47
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl (1975) 1.46
Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am Rev Respir Dis (1990) 1.45
Effect of fecal pollution on Vibrio parahaemolyticus densities in an estuarine environment. Appl Environ Microbiol (1985) 1.43
Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J Biol Chem (1995) 1.41
Effects of propranolol and isosorbide dinitrate on exercise performance and adrenergic acitivity in patients with angina pectoris. Circulation (1969) 1.40
Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res (1993) 1.40
Atrial natriuretic peptide plasma levels during cardiac surgery. J Cardiothorac Anesth (1988) 1.40
Daily rhythmic variation and liver drug metabolism in rats. Biochem Pharmacol (1971) 1.39
Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects. Radiology (1998) 1.39
Membrane filter procedure for enumeration of Vibrio parahaemolyticus. Appl Environ Microbiol (1976) 1.38
Occurrence of male-specific bacteriophage in feral and domestic animal wastes, human feces, and human-associated wastewaters. Appl Environ Microbiol (1998) 1.38
Zolpidem side-effects. Lancet (1993) 1.37
Sympathetic activity and neurotransmitter depletion in congestive heart failure. Pharmacol Rev (1966) 1.35
The adrenergic nervous system in the control of the normal and failing heart. Proc R Soc Med (1965) 1.33
[Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol (1990) 1.31
In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients. Clin Cancer Res (1998) 1.31
Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent. J Chromatogr (1979) 1.30
Gas chromatographic method for the determination of nomifensine in human plasma. J Chromatogr (1976) 1.29
Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet (1981) 1.29
Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychol Med (2000) 1.26
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25
Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris. Circulation (1975) 1.24
Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science (1982) 1.23
Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus. Eur J Clin Pharmacol (1980) 1.23
Norepinephrine stores and contractile force of papillary muscle from the failing human heart. Circulation (1966) 1.23
Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study. Clin Cancer Res (1997) 1.22
Seasonal effects on accumulation of microbial indicator organisms by Mercenaria mercenaria. Appl Environ Microbiol (1992) 1.22
A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology (1997) 1.19
Remifentanil versus remifentanil/midazolam for ambulatory surgery during monitored anesthesia care. Anesthesiology (1997) 1.19
Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat. Biochem Pharmacol (1972) 1.18
Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension. Lancet (1980) 1.18
Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Ann N Y Acad Sci (1971) 1.16
A comparative double-blind trial of the new antidepressant caroxazone and amitriptyline. J Int Med Res (1978) 1.16
Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res (1995) 1.16
Metabolism and Pharmacolinetics of Carbamazepine. Drug Metab Rev (1975) 1.15
Diazepam elimination in premature and full term infants, and children. J Perinat Med (1973) 1.15
Biochemical aspects of the interaction between midbrain raphe and locus coeruleus in the rat. Brain Res (1974) 1.14
Rate of aminopyrine disappearance from plasma in young and aged humans. Pharmacology (1972) 1.13
The effect of muscle damage on strength and fatigue deficits. J Strength Cond Res (2001) 1.12
Pharmacokinetics of nomifensine in man. Psychopharmacologia (1975) 1.12
Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women. Cancer Res (1992) 1.11
Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am J Physiol (1992) 1.11
Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol. J Clin Invest (1973) 1.10
Inter-observer and intra-observer variability of mammogram interpretation: a field study. Eur J Cancer (1992) 1.09
Pharmacokinetic studies of minoxidil. Clin Pharmacol Ther (1972) 1.08
Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor. Am J Hypertens (1992) 1.08
The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes. J Mol Cell Cardiol (1997) 1.08
Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol (1986) 1.08
Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size. Br J Cancer (2005) 1.07
Clincial pharmacokinetics in neonates. Clin Pharmacokinet (1976) 1.07
Prevalence of nightmares and their relationship to psychopathology and daytime functioning in insomnia subjects. Sleep (1997) 1.06
Thromboxane release during percutaneous transluminal coronary angioplasty. Am Heart J (1986) 1.06
Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens. J Pharm Sci (1974) 1.05
Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension (1996) 1.04
The requirements of a specialist Breast Centre. Eur J Cancer (2013) 1.04
Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein. J Biol Chem (1994) 1.02
Monosodium glutamate and the Chinese restaurant syndrome. Nature (1970) 1.02
Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways. J Mol Cell Cardiol (1997) 1.02
Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance. JAMA (1976) 1.02
Endothelins. Biochemistry and pathophysiologic actions. Anesthesiology (1994) 1.02
Pharmacokinetic studies of quinidine in patients with arrhythmias. Circulation (1977) 1.02
Simple sensitive and specific gas chromatographic method for the quantification of diltiazem human body fluids. J Chromatogr (1977) 1.01
Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoplasmic reticulum fractions in hypertrophied and failing rabbit hearts. J Mol Cell Cardiol (1974) 1.01
Angiotensin-II-binding sites on hepatocyte nuclei. Endocrinology (1992) 1.01
Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect. Br J Clin Pharmacol (1976) 1.01
Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia (1988) 1.01
Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications? Arch Neurol (1982) 1.01
A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer's disease. Eur J Neurol (2001) 1.00
Basic metabolites of trazodone in humans. Arzneimittelforschung (1974) 1.00
Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3 : an autocrine loop for hypertrophy. Hypertension (2000) 1.00
Rapid and sensitive method for determination of haloperidol in human samples using nitrogen-phosphorus selective detection. J Chromatogr (1978) 0.99
Changes in plasma thyroxine concentration and metabolism, catecholamine excretion and basal oxygen consumption in man during acute exposure to high altitude. J Clin Endocrinol Metab (1967) 0.99
Phosphorylation of the angiotensin II (AT1A) receptor carboxyl terminus: a role in receptor endocytosis. Mol Endocrinol (1998) 0.98
Metabolic response to a high-fat diet in neonatal and adult rat muscle. Am J Physiol (1992) 0.98
Intracellular calcium and myocardial contractility. 3. Reduced calcium uptake and ATPase of the sarcoplasmic reticular fraction prepared from chronically failing calf hearts. Circ Res (1970) 0.98
Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart. Am J Physiol (1992) 0.98
Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative. Prostaglandins (1982) 0.98
Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography. Cancer Treat Rep (1976) 0.98
Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J (2001) 0.97
Biochemical aspects of Huntington's chorea. J Neurol Neurosurg Psychiatry (1977) 0.97
Studies on plasma protein binding of carbamazepine. Pharmacol Res Commun (1974) 0.97
Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest (1981) 0.97
Cardiac norepinephrine stores and the contractile state of heart muscle. Circ Res (1966) 0.96
Tetrahydropapaveroline: formation in vivo and in vitro in rat brain. Life Sci (1974) 0.96
Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients. Epilepsia (1975) 0.95
Long-term treatment with mianserin: a clinical study with plasma levels. Adv Biochem Psychopharmacol (1982) 0.95
Inter-observer variability in the interpretation of mammograms. Tumori (1988) 0.95